002210 — Dongsung Pharmaceutical Co Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousMicro Cap
Annual cashflow statement for Dongsung Pharmaceutical Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14,079 | -4,313 | -2,122 | -2,074 | -7,253 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 11,099 | 2,363 | 1,316 | 2,530 | 3,607 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5,891 | -3,025 | -5,196 | -6,851 | -8,336 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 5,010 | -2,752 | -3,883 | -4,293 | -9,943 |
| Capital Expenditures | -6,922 | -2,324 | -643 | -924 | -2,467 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 1,283 | -7,376 | 1,281 | -4.15 | -4,395 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5,639 | -9,700 | 638 | -928 | -6,862 |
| Financing Cash Flow Items | -1.35 | 72.2 | -1,052 | 0 | 170 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -3,303 | 1,232 | 4,240 | 7,567 | 13,510 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4,015 | -11,212 | 954 | 2,342 | -3,290 |